Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 3/2012

01.05.2012 | Original Article

Bone development in children and adolescents with PKU

verfasst von: A. B. Mendes, F. F. Martins, W. M. S. Cruz, L. E. da Silva, C.B.M. Abadesso, G.T. Boaventura

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Individuals with phenylketonuria (PKU, OMIM 261600) have shown bone disease from childhood. Factors such as non-adherence to treatment, nutritional inadequacy, and high phenylalanine levels are associated with bone disease in several studies. This research aimed to describe the impact of dietary factors (consumption of energy, protein, calcium, phosphorus, and phenylalanine), and the control of plasma phenylalanine levels on bone age (BA) and bone mineral density (BMD).

Methodology

Thirteen patients of both genders, from 8 to 16 years old participated in this study. Control data were collected of phenylalanine levels, food frequency and record, hand and fist X-rays, and spinal bone densitometry.

Results

In children group (CG), individuals non-adherent to diet (NAD) consumed lower amounts of calcium (472 ± 100 mg/day) and energy (1743 ± 486 Kcal); they had higher rates of phenylalanine (564 ± 94 μmol/L) in blood, intake phenylalanine (701 ± 334 mg/g), and higher protein intake from free foods (14 ± 6.67 g/day); bone age (BA) values higher than the chronological age (CA) and less BMD values (−0.7 ± 1.6 SD) also were verified. In adolescent group (AG, N = 8) of NAD, values were lower for energy intake (1379 ± 258 Kcal), calcium (801 ± 152 mg/day), phosphorus (657 ± 102 mg/day), food protein (25 ± 7.6 g/day), and intake phenylalanine (1067 ± 382 mg/day) than recommended. Higher levels of plasma phenylalanine (851 ± 244 μmol/L), bone age greater than chronological age and lower BMD values (−2.4 ± −2.5 SD) were observed.

Conclusion

The results suggest effects on BA and on BMD, in both children and adolescent groups. The bone development is expressed differently in children and adolescents. The non-adherence to the diet verified in both groups and the consequent imbalance in the nutrients intake involved in bone metabolism suggest that these factors influence the failure to thrive in children and reduced bone mineralization in adolescents.
Literatur
Zurück zum Zitat Acosta PB (1996) Recommendations for protein and energy intakes by patients with phenylketonuria. Eur J Pediatr 155(Suppl 1):136–9CrossRef Acosta PB (1996) Recommendations for protein and energy intakes by patients with phenylketonuria. Eur J Pediatr 155(Suppl 1):136–9CrossRef
Zurück zum Zitat Acosta PA (2003). A guide for the family of the child with phenylketonuria: The Ross Metabolic Formula System. Georgia: Ross Metabolics, p31. Acosta PA (2003). A guide for the family of the child with phenylketonuria: The Ross Metabolic Formula System. Georgia: Ross Metabolics, p31.
Zurück zum Zitat Barat P, Bartle N, Redonnet-Vernhet I et al. (2002) The impact of the control of serum Phenylalanine levels on osteopenia in patients with phenylketonuria. Eur J Pediatr 161:687–88PubMedCrossRef Barat P, Bartle N, Redonnet-Vernhet I et al. (2002) The impact of the control of serum Phenylalanine levels on osteopenia in patients with phenylketonuria. Eur J Pediatr 161:687–88PubMedCrossRef
Zurück zum Zitat Barness M A (1992). Chapter 12: Cálcio, Fósforo e Magnésio, p.115-120. In: Manual de Nutrição Pediátrica. Mead Johnson. Barness M A (1992). Chapter 12: Cálcio, Fósforo e Magnésio, p.115-120. In: Manual de Nutrição Pediátrica. Mead Johnson.
Zurück zum Zitat Bilginsoy C, Waitzman N, Leonard CO, et al. (2005) Living with phenylketonuria:perspectives of patients and their families. J Inherit Metab Dis 28(5):231–244 Bilginsoy C, Waitzman N, Leonard CO, et al. (2005) Living with phenylketonuria:perspectives of patients and their families. J Inherit Metab Dis 28(5):231–244
Zurück zum Zitat Brandão MA, Vieira C, José Gilberto H (1999) Fatores envolvidos no pico de massa óssea. Arq Bras Endocrinol Metab 43(6):401–408CrossRef Brandão MA, Vieira C, José Gilberto H (1999) Fatores envolvidos no pico de massa óssea. Arq Bras Endocrinol Metab 43(6):401–408CrossRef
Zurück zum Zitat Burgard P, van Sprosen FJ (2008) The truth of treatment patients with pehnylketonuria after childhood: The need for a new guideline. J Inherit Metab Dis 31:673–679PubMedCrossRef Burgard P, van Sprosen FJ (2008) The truth of treatment patients with pehnylketonuria after childhood: The need for a new guideline. J Inherit Metab Dis 31:673–679PubMedCrossRef
Zurück zum Zitat Compson J (2006) Bone quality: what is it and how is it measured? Arquiv Bras Endocrinol e Metab 50:579–585 Compson J (2006) Bone quality: what is it and how is it measured? Arquiv Bras Endocrinol e Metab 50:579–585
Zurück zum Zitat Fisberg RM, Villar BS (2002) Tabela Manual de receitas e medidas caseiras para cálculo de inquéritos alimentares. Signus, São Paulo, p 67 Fisberg RM, Villar BS (2002) Tabela Manual de receitas e medidas caseiras para cálculo de inquéritos alimentares. Signus, São Paulo, p 67
Zurück zum Zitat Genaro OS; Martini L (2008). Nutrição Óssea. In: Dossiê Bio. Nestlé. Genaro OS; Martini L (2008). Nutrição Óssea. In: Dossiê Bio. Nestlé.
Zurück zum Zitat Genant HK, Cooper C, Poor G et al. (1999) Interim report and recommendations of the World Health Organization Task-force for Osteoporosis. Osteop Internat 10:242–244 Genant HK, Cooper C, Poor G et al. (1999) Interim report and recommendations of the World Health Organization Task-force for Osteoporosis. Osteop Internat 10:242–244
Zurück zum Zitat Huemer M, Huemer C, Mo¨ slinger D et al. (2007) Growth and body composition in children with classical Phenylketonuria: Results in 34 patients and review of the literature. J Inher Metab Dis 30:694–699PubMedCrossRef Huemer M, Huemer C, Mo¨ slinger D et al. (2007) Growth and body composition in children with classical Phenylketonuria: Results in 34 patients and review of the literature. J Inher Metab Dis 30:694–699PubMedCrossRef
Zurück zum Zitat Longui CA (1996) Determinação da Idade Óssea na avaliação do crescimento. Temas de Pediatria, Nestlé, p 61 Longui CA (1996) Determinação da Idade Óssea na avaliação do crescimento. Temas de Pediatria, Nestlé, p 61
Zurück zum Zitat MacDonald A, Rylance G, Hall SK et al. (1999) The effect frequent administration of protein substitute on plasma phenylalanine concentrations. In: 4th International Dietitians Metabolic Meeting. Birminghan: SSIEM p 19–23. MacDonald A, Rylance G, Hall SK et al. (1999) The effect frequent administration of protein substitute on plasma phenylalanine concentrations. In: 4th International Dietitians Metabolic Meeting. Birminghan: SSIEM p 19–23.
Zurück zum Zitat MacDonald A, Lee P, Davies A et al. (2008) Long-term compliance with a novel vitamin and mineral supplement in older people with PKU. J Inherit Metab Dis 31:718–723PubMedCrossRef MacDonald A, Lee P, Davies A et al. (2008) Long-term compliance with a novel vitamin and mineral supplement in older people with PKU. J Inherit Metab Dis 31:718–723PubMedCrossRef
Zurück zum Zitat Marcondes E (1965) Contribuição para o Estudo do Valor Clínico em Pediatria da Idade Óssea determinada pela Radiografia de Mãos e Punhos. Tese, FMUSP Marcondes E (1965) Contribuição para o Estudo do Valor Clínico em Pediatria da Idade Óssea determinada pela Radiografia de Mãos e Punhos. Tese, FMUSP
Zurück zum Zitat Marcondes E; Chammas F (1966). Valores médios e limites de normalidade da idade óssea em crianças de São Paulo de 9 meses a 12 anos de idade. Rev Hosp Clin Fac Med S Paulo. 27:217. Marcondes E; Chammas F (1966). Valores médios e limites de normalidade da idade óssea em crianças de São Paulo de 9 meses a 12 anos de idade. Rev Hosp Clin Fac Med S Paulo. 27:217.
Zurück zum Zitat Marcondes E (1980) Idade Óssea em Pediatria. Jornal de Pediatria 2:297–311 Marcondes E (1980) Idade Óssea em Pediatria. Jornal de Pediatria 2:297–311
Zurück zum Zitat McMurry PM, Chan GM, Leonard CO, et al (1992) Bone mineral status in children with phenylketonuria relationship to nutritional intake and phenylalanine control. Am J Clin Nutr 55:997–1004 McMurry PM, Chan GM, Leonard CO, et al (1992) Bone mineral status in children with phenylketonuria relationship to nutritional intake and phenylalanine control. Am J Clin Nutr 55:997–1004
Zurück zum Zitat Modan-Moses D, Vered I, Shwartz G et al. (2007) Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 30:202–208PubMedCrossRef Modan-Moses D, Vered I, Shwartz G et al. (2007) Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 30:202–208PubMedCrossRef
Zurück zum Zitat Perez-Duenas B, Cambra FJ, Vilaseca MA et al. (2002) New approach to osteopenia in phenylketonuric patients. Acta Paediatr 91:899–904PubMedCrossRef Perez-Duenas B, Cambra FJ, Vilaseca MA et al. (2002) New approach to osteopenia in phenylketonuric patients. Acta Paediatr 91:899–904PubMedCrossRef
Zurück zum Zitat Pyle SI, Waterhouse AM, Greulich WW (1971) Attributes of the radiographic standard of reference for the National Health Examination Survey. Am J Phys Anthropol 35(3):331–337PubMedCrossRef Pyle SI, Waterhouse AM, Greulich WW (1971) Attributes of the radiographic standard of reference for the National Health Examination Survey. Am J Phys Anthropol 35(3):331–337PubMedCrossRef
Zurück zum Zitat Schaeffer F, Burgard P, Rupp A et al. (1994) Growth and skeletal maturation in children phenylketonuria. Acta Paediatr 83:534–541CrossRef Schaeffer F, Burgard P, Rupp A et al. (1994) Growth and skeletal maturation in children phenylketonuria. Acta Paediatr 83:534–541CrossRef
Zurück zum Zitat Schulz B, Bremer HJ (1995) Nutrient intake and food consumption of adolescents and young adults with phenylketonuria. Act Pæd 84(7):743–748CrossRef Schulz B, Bremer HJ (1995) Nutrient intake and food consumption of adolescents and young adults with phenylketonuria. Act Pæd 84(7):743–748CrossRef
Zurück zum Zitat Zeman J, Bayer M, Stepan J (1999) Bone mineral density in patients with phenylketonúria. Acta Paediatr 88:1348–1351PubMedCrossRef Zeman J, Bayer M, Stepan J (1999) Bone mineral density in patients with phenylketonúria. Acta Paediatr 88:1348–1351PubMedCrossRef
Metadaten
Titel
Bone development in children and adolescents with PKU
verfasst von
A. B. Mendes
F. F. Martins
W. M. S. Cruz
L. E. da Silva
C.B.M. Abadesso
G.T. Boaventura
Publikationsdatum
01.05.2012
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 3/2012
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9412-7

Weitere Artikel der Ausgabe 3/2012

Journal of Inherited Metabolic Disease 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.